273
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Efficacy of different routes of administration for Coenzyme Q10 formulation in noise-induced hearing loss: Systemic versus transtympanic modality

, , , &
Pages 391-399 | Received 03 Oct 2011, Accepted 11 Dec 2011, Published online: 25 Mar 2012

References

  • Henderson D, Bielefeld EC, Harris KC, Hu BH. The role of oxidative stress in noise-induced hearing loss. Ear Hear 2006;27:1–19.
  • Le Prell CG, Yamashita D, Minami SB, Yamasoba T, Miller JM. Mechanisms of noise induced hearing loss indicate multiple methods of prevention. Hear Res 2007;226:22–43.
  • Fetoni AR, Piacentini R, Fiorita A, Paludetti G, Troiani D. Water-soluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL). Brain Res 2009;257:108–16.
  • Fetoni AR, Mancuso C, Eramo SLM, Ralli M, Piacentini R, Barone E, In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea pig. Neuroscience 2010;169:1575–88.
  • Salt AN, Plontke SK. Principles of local drug delivery to the inner ear. Audiol Neurootol 2009;14:350–60.
  • McCall AA, Leary Swan EE, Borenstein JT, Sewell WF, Kujawa SG, McKenna MJ. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear 2010;31:156–65.
  • Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 2007;28:1124–30.
  • Plontke SK, Zimmermann R, Zenner HP, Löwenheim H. Technical note on microcatheter implantation for local inner ear drug delivery: surgical technique and safety aspects. Otol Neurotol 2006;27:912–17.
  • Van Wijck F, Staecker H, Lefebvre PP. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol 2007;127:1012–17.
  • Paulson DP, Abuzeid W, Jiang H, Oe T, O'Malley BW, Li D. A novel controlled local drug delivery system for inner ear disease. Laryngoscope 2008;118:706–11.
  • Plontke SK, Mynatt R, Gill RM, Borgmann S, Salt AN. Concentration gradient along the scala tympani after local application of gentamicin to the round window membrane. Laryngoscope 2007;117:1191–8.
  • Abi-Hachem RN, Zine A, Van De Water TR. The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotective strategies. Recent Pat CNS Drug Discov 2010;5:147–63.
  • Fetoni AR, Ferraresi A, Greca CL, Rizzo D, Sergi B, Tringali G, Antioxidant protection against acoustic trauma by co-administration of idebenone and vitamin E. Neuroreport 2008;19:277–81.
  • Fetoni AR, Ralli M, Sergi B, Parrilla C, Troiani D, Paludetti G. Protective effects of N-acetylcysteine on noise-induced hearing loss in guinea pigs. Acta Otorhinolaryngol Ital 2009;29:70–5.
  • Fetoni AR, Eramo S, Troiani D, Paludetti G. Therapeutic window for ferulic acid protection against noise-induced hearing loss in the guinea pig. Acta Otolaryngol 2011;131:419–27.
  • Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 2001;38:1107–11.
  • Muller M. Frequency representation in the rat cochlea. Hear Res 1991;51:247–54.
  • Lenaz G, Genova ML. Mobility and function of coenzyme Q (ubiquinone) in the mitochondrial respiratory chain. Biochim Biophys Acta 2009;1787:563–73.
  • Pourbakht A, Yamasoba T. Cochlear damage caused by continuous and intermittent noise exposure. Hear Res 2003;178:70–8.
  • Nader ME, Théorêt Y, Saliba I. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity. Laryngoscope 2010;120:1208–13.
  • Swan EE, Mescher MJ, Sewell WF, Tao SL, Borenstein JT. Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 2008;60:1583–99.
  • Wagner N, Cayé-Thomasen P, Laurell G, Bagger-Sjöbäck D, Thomsen J. Cochlear hair cell loss in single-dose versus continuous round window administration of gentamycin. Acta Otolaryngol 2005;125:340–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.